MAM
HAE icon

Morse Asset Management’s Haemonetics HAE Stock Holding History

Morse Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,230
Closed -$407K – 135
2019
Q3 		$407K Sell
3,230
-7,650
-70% -$971K 0.15% 96
2019
Q2 		$1.31M Buy
+10,880
New +$1.07M 0.39% 67

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morse Asset Management's HAE Position: Q4 2019 in Review

Morse Asset Management sold out of Haemonetics (HAE) in Q4 2019, closing a stake of 3,230 shares — an estimated $407K sold.

Morse Asset Management first reported a position in HAE in Q2 2019 and held it in 2 quarters. The position peaked at $1.31M in Q2 2019. 298 funds tracked by Wall St. Rank hold HAE as of Q4 2019.

  • Morse Asset Management reported no remaining Haemonetics position as of Q4 2019 after selling out during the quarter.
  • Morse Asset Management sold 3,230 Haemonetics shares in Q4 2019, an estimated $407K.
  • Morse Asset Management first reported a position in Haemonetics in Q2 2019 and held it in 2 quarters.
  • Morse Asset Management's Haemonetics position peaked at $1.31M in Q2 2019.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q4 2019.

Based on Morse Asset Management's 13F filing for Q4 2019, filed 31 Jan 2020.